Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QIAstat-Dx Meningitis/Encephalitis (ME) Panel

K-Number: K242256 · 2024-10-29

ApplicantQIAGEN GmbH
Decision Date2024-10-29
Product CodePLO
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

QIAstat-Dx Meningitis/Encephalitis (ME) Panel is a medical device manufactured by QIAGEN GmbH. It received FDA 510(k) clearance on 2024-10-29 under approval number K242256. The device is classified under product code PLO. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QIAstat-Dx Meningitis/Encephalitis (ME) Panel?

QIAstat-Dx Meningitis/Encephalitis (ME) Panel is a medical device that received FDA 510(k) clearance on 2024-10-29. It is manufactured by QIAGEN GmbH. The 510(k) number is K242256.

When was QIAstat-Dx Meningitis/Encephalitis (ME) Panel approved by the FDA?

QIAstat-Dx Meningitis/Encephalitis (ME) Panel received FDA 510(k) clearance on 2024-10-29, under approval number K242256.

What company makes QIAstat-Dx Meningitis/Encephalitis (ME) Panel?

QIAstat-Dx Meningitis/Encephalitis (ME) Panel is manufactured by QIAGEN GmbH.

What is the FDA product code for QIAstat-Dx Meningitis/Encephalitis (ME) Panel?

The FDA product code for QIAstat-Dx Meningitis/Encephalitis (ME) Panel is PLO.

Other Devices by QIAGEN GmbH

View all 17 devices →

Related Devices (Code: PLO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.